Brian BohnenkampPartner, FDA and Life Sciences at King & Spalding
Brian Bohnenkamp is a partner in King & Spalding’s FDA and life sciences practice who specializes in regulatory and compliance matters relating to drug, biotechnology and medical device companies. He has extensive experience counseling manufacturers on federal and state transparency laws and regulations, including recently enacted state pricing transparency notification and disclosure requirements. He provides counsel to the Ad Hoc Sunshine and State Law Compliance Group, a coalition of more than 65 pharmaceutical, biotechnology and medical device manufacturers. Brian also regularly counsels manufacturers on a range of fraud and abuse laws, industry codes of conduct, state and local gift bans, compliance program laws and sales representative licensing requirements, as well as government ethics restrictions.